Joe Lennerz, Medical Director, Pathology Innovations at Natera, shared on LinkedIn:
“Hello Brain Computer Interface Community... we are excited to announce our 3rd IBCI-CC Annual Meeting on Friday, October 16, 2026, in Washington, DC. We are hosting this meeting in collaboration with the 103rd ACRM Annual Fall Conference and EXPO on October 12-16, 2026 in Washington, DC.
Briefly, the iBCI-CC is a collaborative community with FDA recognition that focusses on implantable brain-computer interfaces. iBCIs have the potential to transform the lives of individuals with neurological conditions by enabling them to live a more independent lifestyle. Realizing this potential requires a collective approach that bridges expertise across various domains.
This meeting is our opportunity to come together (both in person and virtually) to explore the many important viewpoints that shape our field and to identify solutions to some of its major challenges.
The first portion of the event will be a Public Meeting, which will include updates on community efforts, a keynote address from Martha Morrell. The second half will feature an iBCI-CC Members Workshop, with breakout discussions centered on high priority topics and Workgroup planning.
Oh, I forgot to mention… registration for the Annual Meeting is free.
Registration. More about iBCI-cc.”
Other articles featuring Joe Lennerz on OncoDaily.